Clinical Trial Update: Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing docetaxel plus S-1 versus S-1 plus cisplatin in curatively resected stage IIIB/IV gastric cancer. The current status of the trial is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Gastric Adenocarcinoma | Phase 3 | Status: UNKNOWN